These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
110 results:

  • 1. Assessing the Sensitivity of Nested PCR Followed by Direct Sequencing on Exosomal DNA for egfr Mutation Detection in NSCL.
    Jahani MM; Mashayekhi P; Omrani MD; Khosravi A; Ali D; Azad Manjiri S; Zahraei M; Mabani M; Seifi S; Salimi B; Rostami P
    Iran Biomed J; 2024 Jul; 28(4):208-15. PubMed ID: 39289877
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)].
    Oncology Society of Chinese Medical Association
    Zhonghua Yi Xue Za Zhi; 2024 Sep; 104(34):3175-3213. PubMed ID: 39193605
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Pathological Diagnostic Testing and Biomarkers for Perioperative System Therapy].
    Erber R
    Zentralbl Chir; 2024 Aug; 149(S 01):S13-S25. PubMed ID: 39137758
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected lung cancer: A Case Report.
    Hung CM; Wu CT; Jain S; Wu CE
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125693
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)].
    Oncology Society of Chinese Medical Association
    Zhonghua Zhong Liu Za Zhi; 2024 Sep; 46(9):805-843. PubMed ID: 39045625
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of postoperative recurrence-free survival in non-small cell lung cancer patients based on consensus clustering.
    Tian Q; Zhou SY; Qin YH; Wu YY; Qin C; Zhou H; Shi J; Duan SF; Feng F
    Clin Radiol; 2024 Oct; 79(10):e1214-e1225. PubMed ID: 39039007
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of lung cancer.
    Spicer JD; Cascone T; Wynes MW; Ahn MJ; Dacic S; Felip E; Forde PM; Higgins KA; Kris MG; Mitsudomi T; Provencio M; Senan S; Solomon BJ; Tsao MS; Tsuboi M; Wakelee HA; Wu YL; Chih-Hsin Yang J; Zhou C; Harpole DH; Kelly KL
    J Thorac Oncol; 2024 Oct; 19(10):1373-1414. PubMed ID: 38901648
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Study on Targeted Drugs for Non-small cell NSCLC with PD-1PD-L1 Signaling Pathway.
    Cao X
    Stud Health Technol Inform; 2023 Nov; 308():562-567. PubMed ID: 38007784
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Perioperative Durvalumab for Resectable Non-small-cell lung cancer.
    Heymach JV; Harpole D; Mitsudomi T; Taube JM; Galffy G; Hochmair M; Winder T; Zukov R; Garbaos G; Gao S; Kuroda H; Ostoros G; Tran TV; You J; Lee KY; Antonuzzo L; Papai-Szekely Z; Akamatsu H; Biswas B; Spira A; Crawford J; Le HT; Aperghis M; Doherty GJ; Mann H; Fouad TM; Reck M;
    N Engl J Med; 2023 Nov; 389(18):1672-1684. PubMed ID: 37870974
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A real-world study comparing perioperative chemotherapy and egfr-tyrosine kinase inhibitors for treatment of resected stage III egfr-mutant adenocarcinoma.
    Chen CL; Wang ST; Liao WC; Chen CH; Tu CY; Hsia TC; Cheng WC; Chen HJ
    BMC Cancer; 2023 Sep; 23(1):847. PubMed ID: 37697233
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Alterations and the Incidence of Brain Metastases in Advanced and Metastatic NSCLC: A Systematic Review and Meta-Analysis.
    Gillespie CS; Mustafa MA; Richardson GE; Alam AM; Lee KS; Hughes DM; Escriu C; Zakaria R
    J Thorac Oncol; 2023 Dec; 18(12):1703-1713. PubMed ID: 37392903
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical characteristics of miliary pulmonary metastases in non-small cell lung cancer.
    Choi H; Im Y; Jeong BH; Lee K; Kim H; Um SW
    Thorac Cancer; 2023 Aug; 14(22):2168-2176. PubMed ID: 37337934
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [A Case of Multiple Brain Metastases after Surgery for lung cancer Successfully Treated with Osimertinib].
    Takeuchi K; Hayakawa N; Ouchi M
    Gan To Kagaku Ryoho; 2023 May; 50(5):631-633. PubMed ID: 37218327
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of brain radiotherapy for egfr- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
    Nardone V; Romeo C; D'Ippolito E; Pastina P; D'Apolito M; Pirtoli L; Caraglia M; Mutti L; Bianco G; Falzea AC; Giannicola R; Giordano A; Tagliaferri P; Vinciguerra C; Desideri I; Loi M; Reginelli A; Cappabianca S; Tassone P; Correale P
    Radiol Med; 2023 Mar; 128(3):316-329. PubMed ID: 36786970
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic Associations of
    Chang SL; Yang PJ; Lin YY; Jiang YJ; Liu PI; Huang CL; Yang SF; Tang CH
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429891
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A novel egfr exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.
    Zhou T; Xiong Q; Hong C; Wang Q; Wang W; Xu C; Cai J;
    Medicine (Baltimore); 2022 Aug; 101(34):e30269. PubMed ID: 36042660
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.
    Soo R; Mery L; Bardot A; Kanesvaran R; Keong TC; Pongnikorn D; Prasongsook N; Hutajulu SH; Irawan C; Manan AA; Thiagarajan M; Sripan P; Peters S; Storm H; Bray F; Stahel R
    ESMO Open; 2022 Oct; 7(5):100560. PubMed ID: 35988454
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING egfr and ALK MUTATION in PATIENTS with NON-small cell lung cancer.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer.
    Jang SH; Lee DY; Jeong J; Choi WI
    Korean J Intern Med; 2022 Jul; 37(4):811-820. PubMed ID: 35811369
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Delineating and sparing functional nephrons for radiotherapy in the case of lymphoma with polycystic kidney disease.
    Gurusamy VM; Chandramouli SH; Usman M; Divakar SR; Hammoud RW; Al-Hammadi N
    Cancer Treat Res Commun; 2022; 31():100566. PubMed ID: 35487053
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.